Literature DB >> 12657068

The last 2 years of life: functional trajectories of frail older people.

Kenneth E Covinsky1, Catherine Eng, Li-Yung Lui, Laura P Sands, Kristine Yaffe.   

Abstract

OBJECTIVES: To characterize the functional trajectories during the last 2 years of life of patients with progressive frailty, with and without cognitive impairment, and to assess whether it was possible to identify discrete functional indicators that signal the end of life.
DESIGN: A retrospective analysis of functional trajectories during the last 24 months of life.
SETTING: Twelve demonstration sites of the Program of All-inclusive Care for the Elderly (PACE). PACE cares for frail older people who meet criteria for nursing home placement, with the goal of keeping the patient at home. PARTICIPANTS: Nine hundred seventeen patients who died while enrolled in PACE. MEASURES: At PACE entry and every 3 months thereafter, data were collected about the degree of dependence (none, partial, or full) in bathing, eating, and walking and the degree of incontinence (none, bladder, or bowel). Cognitive impairment was defined as six or more errors on the Short Portable Mental Status Questionnaire. To describe the end-of-life trajectories of patients, data were analyzed from observational windows of time, beginning with the patients' dates of death and extending backward in time to 24 months before death. Each analytical window was 3 months in duration. For each of the functional measures, the probability of functional deterioration in the last 2 years of life in patients with (64%) and without (36%) cognitive impairment was also compared.
RESULTS: The mean age at death was 84; 69% of patients were women. For patients with and without cognitive impairment, a prolonged, steady increase in the rates of functional dependence that were evident at least 1 year before death, rather than sudden increases in functional dependence shortly before death, characterized the functional trajectories. It was not possible for any of the four measures to detect a time point before death at which there was an abrupt decline in function likely to signal impending death. For each measure, patients with cognitive impairment declined earlier, were more likely than patients without cognitive impairment to have the maximal level of dependence in the 0- to 3-month window before death (e.g., 56% vs 30% for mobility, P <.001), and were more likely to decline in the 2 years before death (e.g., 56% vs 36% for mobility, P <.001).
CONCLUSION: Patients with advanced frailty, with or without cognitive impairment, have an end-of-life functional course marked by slowly progressive functional deterioration, with only a slight acceleration in the trajectory of functional loss as death approaches. Patients with cognitive impairment have particularly high rates of functional impairment at the time of death. These results suggest that end-of-life care systems that are targeted toward patients with functional trajectories clearly suggesting impending death (such as the Medicare hospice benefit) are poorly suited to older people dying with progressive frailty.

Entities:  

Mesh:

Year:  2003        PMID: 12657068     DOI: 10.1046/j.1532-5415.2003.51157.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  50 in total

1.  Quality of life in late-life disability: "I don't feel bitter because I am in a wheelchair".

Authors:  Jennifer King; Lindsey Yourman; Cyrus Ahalt; Catherine Eng; Sara J Knight; Eliseo J Pérez-Stable; Alexander K Smith
Journal:  J Am Geriatr Soc       Date:  2012-01-30       Impact factor: 5.562

2.  Disability Stage is an Independent Risk Factor for Mortality in Medicare Beneficiaries Aged 65 Years and Older.

Authors:  Sean Hennessy; Jibby E Kurichi; Qiang Pan; Joel E Streim; Hillary R Bogner; Dawei Xie; Margaret G Stineman
Journal:  PM R       Date:  2015-05-21       Impact factor: 2.298

Review 3.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

Review 4.  Identification and management of frailty in the primary care setting.

Authors:  Marjan Abbasi; Darryl Rolfson; Amandeep S Khera; Julia Dabravolskaj; Elsa Dent; Linda Xia
Journal:  CMAJ       Date:  2018-09-24       Impact factor: 8.262

5.  Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-09-19       Impact factor: 5.562

6.  Every patient is an individual: clinicians balance individual factors when discussing prognosis with diverse frail elderly adults.

Authors:  Julie N Thai; Louise C Walter; Catherine Eng; Alexander K Smith
Journal:  J Am Geriatr Soc       Date:  2013-01-15       Impact factor: 5.562

7.  End-of-life care preferences and needs: perceptions of patients with chronic kidney disease.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

8.  Characteristics and outcomes of hospice enrollees with dementia discharged alive.

Authors:  Kimberly S Johnson; Katja Elbert-Avila; Maragatha Kuchibhatla; James A Tulsky
Journal:  J Am Geriatr Soc       Date:  2012-08-20       Impact factor: 5.562

9.  Pain as a risk factor for disability or death.

Authors:  James S Andrews; Irena Stijacic Cenzer; Edward Yelin; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2013-03-21       Impact factor: 5.562

10.  Research participation by older adults at end of life: barriers and solutions.

Authors:  Melissa Lehan Mackin; Keela Herr; Kimberly Bergen-Jackson; Perry Fine; Chris Forcucci; Sara Sanders
Journal:  Res Gerontol Nurs       Date:  2009-04-30       Impact factor: 1.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.